News
24/7 Wall St. on MSN1h
Prediction: 1 Biotech Stock That Could Surpass Pfizer by 2030Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a $128 billion market cap. Renowned for its blockbuster drugs like Lipitor ...
In April 2025, Kamau Therapeutics announced a study is a first-in-human, single-arm, open-label Phase I/II study of nula-cel ...
I thought you could help with a stubborn problem. I am a healthy and active 78-year-old woman who, I admit, likes to look ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback